170 related articles for article (PubMed ID: 25870133)
1. Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent.
Kim YS; Zhou Y; Bryant H; Milenic DE; Baidoo KE; Lewis BK; Frank JA; Brechbiel MW
Bioorg Med Chem Lett; 2015; 25(10):2056-9. PubMed ID: 25870133
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of αvβ₃-targeting peptidomimetic chelate conjugates for PET and SPECT imaging.
Kim YS; Nwe K; Milenic DE; Brechbiel MW; Satz S; Baidoo KE
Bioorg Med Chem Lett; 2012 Sep; 22(17):5517-22. PubMed ID: 22853992
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.
Jang BS; Lim E; Hee Park S; Shin IS; Danthi SN; Hwang IS; Le N; Yu S; Xie J; Li KC; Carrasquillo JA; Paik CH
Nucl Med Biol; 2007 May; 34(4):363-70. PubMed ID: 17499725
[TBL] [Abstract][Full Text] [Related]
4. cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).
Goswami LN; Ma L; Cai Q; Sarma SJ; Jalisatgi SS; Hawthorne MF
Inorg Chem; 2013 Feb; 52(4):1701-9. PubMed ID: 23391150
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
6. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.
Kotková Z; Helm L; Kotek J; Hermann P; Lukeš I
Dalton Trans; 2012 Nov; 41(43):13509-19. PubMed ID: 23018269
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
Dijkgraaf I; Kruijtzer JA; Frielink C; Soede AC; Hilbers HW; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC
Nucl Med Biol; 2006 Nov; 33(8):953-61. PubMed ID: 17127167
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.
Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B
Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562
[TBL] [Abstract][Full Text] [Related]
10. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.
Zhou Z; Han Z; Lu ZR
Biomaterials; 2016 Apr; 85():168-79. PubMed ID: 26874280
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ 3 integrin.
Debergh I; Van Damme N; De Naeyer D; Smeets P; Demetter P; Robert P; Carme S; Pattyn P; Ceelen W
Ann Surg Oncol; 2014 Jun; 21(6):2097-104. PubMed ID: 24356800
[TBL] [Abstract][Full Text] [Related]
12. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
[TBL] [Abstract][Full Text] [Related]
13. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X
ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632
[TBL] [Abstract][Full Text] [Related]
14. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
[TBL] [Abstract][Full Text] [Related]
15. Gallium labeled NOTA-based conjugates for peptide receptor-mediated medical imaging.
de Sá A; Matias AA; Prata MI; Geraldes CF; Ferreira PM; André JP
Bioorg Med Chem Lett; 2010 Dec; 20(24):7345-8. PubMed ID: 21106453
[TBL] [Abstract][Full Text] [Related]
16. Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.
Huo T; Du X; Zhang S; Liu X; Li X
Eur J Radiol; 2010 Feb; 73(2):420-7. PubMed ID: 19261416
[TBL] [Abstract][Full Text] [Related]
17. Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents.
Gu S; Kim HK; Lee GH; Kang BS; Chang Y; Kim TJ
J Med Chem; 2011 Jan; 54(1):143-52. PubMed ID: 21141934
[TBL] [Abstract][Full Text] [Related]
18. A tripodal ruthenium-gadolinium metallostar as a potential α(v)β(3) integrin specific bimodal imaging contrast agent.
Verwilst P; Eliseeva SV; Vander Elst L; Burtea C; Laurent S; Petoud S; Muller RN; Parac-Vogt TN; De Borggraeve WM
Inorg Chem; 2012 Jun; 51(11):6405-11. PubMed ID: 22583122
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
